Dashboard
Financial statements
A

Company financials

Agilent Technologies

Health Care Life Sciences Tools & Services Santa Clara, California Last filing Dec 22, 2025 · FY2025
Revenue FY2025
$6.9B
3y CAGR +0.5% P17
Net income FY2025
$1.3B
Net margin +18.8% P77
Total assets FY2025
$12.7B
ROA +10.2% P72
Operating cash flow FY2025
$1.6B
FCF margin +16.6% P55
20 yrs · FY2006–FY2025 9 filed · 0 derived · 0 blank

Balance Sheet

Assets, liabilities, and equity

31 accounts · 5 years
Total assets $12.7B
Total liabilities $6.0B
Shareholders equity $6.7B
Account 2025 2024 2023 2022 2021 Trend
Assets
Cash and Cash Equivalents $1.8B 34.6% $1.3B -16.4% $1.6B 51.0% $1.1B -29.0% $1.5B
Short Term Investments $0 $0 $0
Accounts Receivable $1.5B 12.3% $1.3B 2.6% $1.3B -8.1% $1.4B 19.9% $1.2B
Inventory $1.0B 5.5% $972.0M -5.7% $1.0B
Prepaid Expenses $293.0M -12.3% $334.0M 21.9% $274.0M
Other Current Assets $293.0M -12.3% $334.0M 21.9% $274.0M
Total Current Assets $4.6B 16.0% $4.0B -5.4% $4.2B 10.8% $3.8B -0.6% $3.8B
Property,Plant and Equipment $2.0B 13.8% $1.8B 40.0% $1.3B 15.5% $1.1B 16.4% $945.0M
Operating Lease Assets $183.0M 3.4% $177.0M 14.9% $154.0M 2.7% $150.0M -15.7% $178.0M
Goodwill $4.5B -0.1% $4.5B 13.1% $4.0B 0.2% $4.0B -0.6% $4.0B
Intangible Assets $445.0M -18.6% $547.0M 15.2% $475.0M
Long Term Investments $133.0M -24.0% $175.0M 6.7% $164.0M -15.9% $195.0M 5.4% $185.0M
Other Noncurrent Assets $1.1B 16.4% $910.0M 28.5% $708.0M 3.2% $686.0M -16.3% $820.0M
Total Assets $12.7B 7.4% $11.8B 10.1% $10.8B 2.2% $10.5B -1.6% $10.7B
Liabilities
Accounts Payable $570.0M 5.6% $540.0M 29.2% $418.0M -27.9% $580.0M 30.0% $446.0M
Accrued Liabilities $443.0M -14.8% $520.0M 17.1% $444.0M -29.4% $629.0M -6.0% $669.0M
Deferred Revenue $624.0M 14.7% $544.0M 7.7% $505.0M
Current Portion of Long Term Debt $304.0M 575.6% $45.0M $0
Total Current Liabilities $2.3B 23.9% $1.9B 18.2% $1.6B -13.9% $1.9B 9.0% $1.7B
Long Term Debt $3.0B -8.8% $3.3B 22.3% $2.7B 0.1% $2.7B 0.1% $2.7B
Deferred Revenue Noncurrent $624.0M 14.7% $544.0M 7.7% $505.0M
Other Noncurrent Liabilities $463.0M -19.9% $578.0M 21.2% $477.0M -11.0% $536.0M -18.7% $659.0M
Total Liabilities $6.0B 0.6% $5.9B 20.9% $4.9B -5.9% $5.2B -1.7% $5.3B
Equity
Preferred Stock $0 $0 $0 $0 $0
Common Stock $3.0M 0.0% $3.0M 0.0% $3.0M 0.0% $3.0M 0.0% $3.0M
Additional Paid In Capital $5.6B 2.3% $5.5B 1.2% $5.4B 1.2% $5.3B 0.1% $5.3B
Retained Earnings $1.4B 85.2% $750.0M -4.1% $782.0M
Treasury Stock $0 $0 $0
Accumulated Other Comprehensive Income $-226.0M 25.9% $-305.0M 6.7% $-327.0M
Total Stockholders Equity $6.7B 14.3% $5.9B 0.9% $5.8B 10.2% $5.3B -1.6% $5.4B
Total Liabilitiesand Equity $12.7B 7.4% $11.8B 10.1% $10.8B 2.2% $10.5B -1.6% $10.7B

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 5 years
Ratio 2025 2024 2023 2022 2021
Profitability
Gross margin +52.4% +54.3% +50.7% +54.4% +53.9%
Operating margin +21.3% +22.9% +19.8% +23.6% +21.3%
Net margin +18.8% +19.8% +18.1% +19.1%
FCF margin +16.6% +21.1% +21.6% +14.9% +20.5%
Growth
Revenue CAGR (3y) +0.5% +1.0% +8.6% +9.9% +8.7%
Returns
ROE +19.3% +21.9% +21.2% +22.5%
ROA +10.2% +10.9% +11.5% +11.3%
ROIC +16.2% +15.8% +17.9% +23.0% +20.3%
Liquidity
Current ratio 1.96x 2.09x 2.61x 2.03x 2.22x
Quick ratio 1.40x 1.40x 1.80x 1.32x 1.56x
Leverage
D/E 0.89x 1.01x 0.84x 0.99x 0.99x
Interest coverage 13.21x 15.50x 14.21x 19.26x 16.63x
Efficiency
Asset turnover 0.55x 0.55x 0.63x 0.65x 0.59x
Cash conversion cycle +128d +127d +135d +128d +116d

Valuation

Price against fundamentals

A $115 · 2026-04-02 · 166d old · FY2025
Market cap $32.9B
P/E 25.26x
P/S 4.74x
P/B 4.88x
EV $34.5B
EV/EBITDA 19.51x
FCF yield +3.5%
Dividend yield +0.9%

Notes

Your annotations

Not watched
Saving notes adds A to your watchlist.